SEC FORM 4
$8,759.76
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Sale of 1,921 shares at $4.56 per share.
Reporting Person Reynoso Jamie L. · Officer Title CEO, Medicare Advantage · Transaction Code S
Traded Sep 17, 2026 · Disclosed Sep 18, 2026
Source: SEC Form 4 · 0001839066-26-000047 · filed 2026-09-18 · View filing →